Pacific Edge surges; NZX 50 falls

Pacific Edge surges; NZX 50 falls
Dan Brunskill
Shares in cancer diagnostic firm Pacific Edge skyrocketed, climbing more than 20% on a deal with a large US insurer, even as the wider share market edged lower.The S&P/NZX 50 Index fell 58.25 points, or 0.5%, to 12,574.35. Within the index, 23 stocks fell, 21 rose, and six were unchanged. Turnover was $203.1 million.Pacific Edge was the best performer by a wide margin. Investors added $100m, or more than a fifth, to the cancer diagnostic firm’s market capitalisation after its Cxbladder test was approved by the biggest healthcare group...

More Markets

NZ sharemarket falls 1%
Markets Market close

NZ sharemarket falls 1%

The S&P/NZX 50 Index closed at 11,804.84, down 111.94 points or 0.94%.

Graham Skellern 16 Apr 2024
Fletcher subsidiary Easysteel looks to cut jobs
Markets

Fletcher subsidiary Easysteel looks to cut jobs

Workers left 'stunned' by company's restructuring proposal, First Union says.

Gregor Thompson 16 Apr 2024
Scott Tech revenue up but profit down
Markets

Scott Tech revenue up but profit down

Scott Technology’s profit fell 42% on one-off costs in the half year to Feb 29 2024, but revenue is up 11% to $141 million on the back of a company refocus.Scott specialises in automated and robotic manufacturing processes. It attributed its revenue growth to its Scott 2027 strat...

Staff reporters 16 Apr 2024
NZX in for a tongue-lashing at AGM
Markets

NZX in for a tongue-lashing at AGM

A proposed 38% increase in the pool for directors' fees is not universally applauded.

Pattrick Smellie 16 Apr 2024